Global Information
회사소개 | 문의 | 위시리스트

최소침습 수술 기기 : 의료기기 파이프라인 평가

Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 02월 상품 코드 346494
페이지 정보 영문 115 Pages
가격
US $ 2,500 ₩ 3,055,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,111,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 9,166,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


최소침습 수술 기기 : 의료기기 파이프라인 평가 Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 02월 페이지 정보 : 영문 115 Pages

최소침습 수술 기기(Minimally Invasive Surgical Devices) 파이프라인 제품의 각 개발 단계 비교 분석, 파이프라인 제품 개발 주요 참여기업 개요, 현재 임상시험 진행중인 파이프라인 제품 정보 등을 전해드립니다.

제1장 목차

제2장 서론

  • 최소침습 수술 기기 개요

제3장 개발중인 제품

  • 최소침습 수술 기기 : 개발 단계별 파이프라인 제품
  • 최소침습 수술 기기 : 국가(지역)별 파이프라인 제품
  • 최소침습 수술 기기 : 규제별 파이프라인 제품
  • 최소침습 수술 기기 : 인증 시기별(추정) 파이프라인 제품
  • 최소침습 수술 기기 : 현재 진행중인 임상시험

제4장 최소침습 수술 기기 : 개발중인 파이프라인 제품 - 기업별

  • 최소침습 수술 기기 기업 : 개발 단계별 파이프라인 제품
  • 최소침습 수술 기기 : 개발 단계별 파이프라인 제품

제5장 최소침습 수술 기기 기업과 제품 개요

  • Actuated Medical, Inc. : 기업 개요
    • Actuated Medical, Inc. : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Centerline Biomedical Inc. : 기업 개요
    • Centerline Biomedical Inc. : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Delft University of Technology : 기업 개요
    • Delft University of Technology : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • DistalMotion : 기업 개요
    • DistalMotion : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Ethicon Endo-Surgery, Inc. : 기업 개요
    • Ethicon Endo-Surgery, Inc. : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • FlexDex : 기업 개요
    • FlexDex : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Flinders University : 기업 개요
    • Flinders University : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Hadassah Medical Organization : 기업 개요
    • Hadassah Medical Organization : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Human Extensions LTD : 기업 개요
    • Human Extensions LTD : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Imperial College London : 기업 개요
    • Imperial College London : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Intuitive Surgical, Inc. : 기업 개요
    • Intuitive Surgical, Inc. : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Technische Universiteit Eindhoven : 기업 개요
    • Technische Universiteit Eindhoven : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • The Johns Hopkins University : 기업 개요
    • The Johns Hopkins University : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • University of California, San Francisco : 기업 개요
    • University of California, San Francisco : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • University of Wisconsin-Stout : 기업 개요
    • University of Wisconsin-Stout : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • Varada Innovations Inc. : 기업 개요
    • Varada Innovations Inc. : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • VenX Medical LLC : 기업 개요
    • VenX Medical LLC : 파이프라인 제품과 현재 진행중인 임상시험 개요
  • XACT Robotics Ltd. : 기업 개요
    • XACT Robotics Ltd. : 파이프라인 제품과 현재 진행중인 임상시험 개요

제6장 최소침습 수술 기기 : 최근 동향

제7장 부록

LSH 15.12.18

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

  • Table 1: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development
  • Table 2: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Territory
  • Table 3: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Regulatory Path
  • Table 4: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Estimated Approval Date
  • Table 5: Minimally Invasive Surgical (MIS) devices - Ongoing Clinical Trials
  • Table 6: Minimally Invasive Surgical (MIS) devices Companies - Pipeline Products by Stage of Development
  • Table 7: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development
  • Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Status
  • Table 10: Grip-Act-Reposition (GAR) Miniaturized Stable Working Platform - Product Description
  • Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Endo-Luminal Surgery Tool - Product Status
  • Table 13: Endo-Luminal Surgery Tool - Product Description
  • Table 14: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Fiber-Top Controlled Adaptable Stiffness Needle - Product Status
  • Table 16: Fiber-Top Controlled Adaptable Stiffness Needle - Product Description
  • Table 17: Low-friction Surgical Grasper - Product Status
  • Table 18: Low-friction Surgical Grasper - Product Description
  • Table 19: System With Shared Control Of Robotic Needle - Product Status
  • Table 20: System With Shared Control Of Robotic Needle - Product Description
  • Table 21: DistalMotion Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Disposable Surgical Device - Product Status
  • Table 23: Disposable Surgical Device - Product Description
  • Table 24: Reusable Surgical Device - Product Status
  • Table 25: Reusable Surgical Device - Product Description
  • Table 26: Eindhoven University of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: PITON Teleoperated Steerable Needle System - Product Status
  • Table 28: PITON Teleoperated Steerable Needle System - Product Description
  • Table 29: ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: CLI Endostapler - Product Status
  • Table 31: CLI Endostapler - Product Description
  • Table 32: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Magnetic Anchoring And Guidance System - Product Status
  • Table 34: Magnetic Anchoring And Guidance System - Product Description
  • Table 35: FlexDex Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Second Generation FlexDex needle Driver - Product Status
  • Table 37: Second Generation FlexDex needle Driver - Product Description
  • Table 38: Fortimedix BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: symphonX - TaCR - Product Status
  • Table 40: symphonX - TaCR - Product Description
  • Table 41: Ictero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: CholeSafe System - Product Status
  • Table 43: CholeSafe System - Product Description
  • Table 44: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: iSnake Surgical System - Product Status
  • Table 46: iSnake Surgical System - Product Description
  • Table 47: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Dexterous Tool For Minimally Invasive Surgery - Product Status
  • Table 49: Dexterous Tool For Minimally Invasive Surgery - Product Description
  • Table 50: Lapovations LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: AbGrab - Product Status
  • Table 52: AbGrab - Product Description
  • Table 53: Magnets In Me Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Magnamosis - Compression Anastomosis - Product Status
  • Table 55: Magnamosis - Compression Anastomosis - Product Description
  • Table 56: Magnets In Me Inc - Ongoing Clinical Trials Overview
  • Table 57: Magnamosis - Compression Anastomosis - Magnetic Compression Anastomosis (Magnamosis) First-in-human Study of Feasibility and Safety
  • Table 58: Osaka University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Minimal Access Surgical Instrument - Product Status
  • Table 60: Minimal Access Surgical Instrument - Product Description
  • Table 61: Purdue University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Surgical Master-Slave Manipulator - Product Status
  • Table 63: Surgical Master-Slave Manipulator - Product Description
  • Table 64: Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Surgical Device - Minimally Invasive Surgery - Product Status
  • Table 66: Surgical Device - Minimally Invasive Surgery - Product Description
  • Table 67: Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Signum Surgically Implanted Device - Product Status
  • Table 69: Signum Surgically Implanted Device - Product Description
  • Table 70: Sonex Health LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: SX-One MicroKnife - Product Status
  • Table 72: SX-One MicroKnife - Product Description
  • Table 73: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Minimally Invasive Device - Gastrointestinal Bleeding - Product Status
  • Table 75: Minimally Invasive Device - Gastrointestinal Bleeding - Product Description
  • Table 76: UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: UltraSurge's Device - Product Status
  • Table 78: UltraSurge's Device - Product Description
  • Table 79: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Transcolonic Overtube For NOTES - Product Status
  • Table 81: Transcolonic Overtube For NOTES - Product Description
  • Table 82: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Interleaved Continuum-rigid Manipulator - Product Status
  • Table 84: Interleaved Continuum-rigid Manipulator - Product Description
  • Table 85: Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: ArthroTense - Product Status
  • Table 87: ArthroTense - Product Description
  • Table 88: VenX Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: VenX Reach - Product Status
  • Table 90: VenX Reach - Product Description
  • Table 91: VenX Medical LLC (Inactive) - Ongoing Clinical Trials Overview
  • Table 92: VenX Reach - First-In-Man Study Using VenX Reach for the Treatment of Varicose Veins
  • Table 93: Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Magnetoelectric Device - Product Status
  • Table 95: Magnetoelectric Device - Product Description
  • Table 96: Glossary

List of Figures

  • Figure 1: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development
  • Figure 2: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Territory
  • Figure 3: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Regulatory Path
  • Figure 4: Minimally Invasive Surgical (MIS) devices - Pipeline Products by Estimated Approval Date
  • Figure 5: Minimally Invasive Surgical (MIS) devices - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Minimally Invasive Surgical (MIS) Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Minimally Invasive Surgical (MIS) Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Minimally Invasive Surgical (MIS) devices Overview

3 Products under Development

  • 3.1 Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development
  • 3.2 Minimally Invasive Surgical (MIS) devices - Pipeline Products by Territory
  • 3.3 Minimally Invasive Surgical (MIS) devices - Pipeline Products by Regulatory Path
  • 3.4 Minimally Invasive Surgical (MIS) devices - Pipeline Products by Estimated Approval Date
  • 3.5 Minimally Invasive Surgical (MIS) devices - Ongoing Clinical Trials

4 Minimally Invasive Surgical (MIS) devices - Pipeline Products under Development by Companies

  • 4.1 Minimally Invasive Surgical (MIS) devices Companies - Pipeline Products by Stage of Development
  • 4.2 Minimally Invasive Surgical (MIS) devices - Pipeline Products by Stage of Development

5 Minimally Invasive Surgical (MIS) devices Companies and Product Overview

  • 5.1 Actuated Medical Inc Company Overview
  • 5.2 Boston Scientific Corp Company Overview
  • 5.3 Delft University of Technology Company Overview
  • 5.4 DistalMotion Company Overview
  • 5.5 Eindhoven University of Technology Company Overview
  • 5.6 ES Vascular Ltd. Company Overview
  • 5.7 Ethicon Endo-Surgery Inc Company Overview
  • 5.8 FlexDex Company Overview
  • 5.9 Fortimedix BV Company Overview
  • 5.10 Ictero Medical Inc Company Overview
  • 5.11 Imperial College London Company Overview
  • 5.12 Johns Hopkins University Company Overview
  • 5.13 Lapovations LLC Company Overview
  • 5.14 Magnets In Me Inc Company Overview
  • 5.15 Osaka University Company Overview
  • 5.16 Purdue University Company Overview
  • 5.17 Rambam Health Care Campus Company Overview
  • 5.18 Signum Surgical Ltd Company Overview
  • 5.19 Sonex Health LLC Company Overview
  • 5.20 Stanford University Company Overview
  • 5.21 UltraSurge Technologies Ltd. Company Overview
  • 5.22 University of South Florida Company Overview
  • 5.23 University of Wisconsin Madison Company Overview
  • 5.24 Varada Innovations Inc. Company Overview
  • 5.25 VenX Medical LLC (Inactive) Company Overview
  • 5.26 Virginia Commonwealth University Company Overview

6 Minimally Invasive Surgical (MIS) devices- Recent Developments

  • 6.1 Jul 19, 2018: Intuitive Surgical announces financial results for the quarter ended June 30, 2018
  • 6.2 Jul 10, 2018: ReShape Life sciences Expands Intra-gastric Balloon Business to Include Brigham and Women's Hospital in Boston
  • 6.3 Jul 10, 2018: Stryker announces organizational changes
  • 6.4 Jul 09, 2018: Titan Medical Announces Achievement of all Second Quarter 2018 SPORT Surgical System Development Milestones
  • 6.5 Jul 02, 2018: Northwestern Memorial Hospital First in Illinois to Complete Robotic Tracheoplasty on Patient with Tracheobronchomalacia
  • 6.6 Jun 28, 2018: Titan Medical Names Domenic Serafino As Board Director
  • 6.7 Jun 21, 2018: First major study comparing robotic to open surgery published in The Lancet
  • 6.8 Jun 13, 2018: InstruSafe by Summit Medical Launches New Trays for da Vinci SP Surgical System Instrumentation
  • 6.9 Jun 12, 2018: Cook Medical to convert former cigarette facility to medical device manufacturing
  • 6.10 Jun 08, 2018: Beebe Healthcare Introduces the da Vinci Xi Robotic Surgical System
  • 6.11 Jun 06, 2018: FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
  • 6.12 Jun 06, 2018: FlexDex, Inc. Appoints New Vice President, Research and Development and Vice President, International Sales and Marketing
  • 6.13 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
  • 6.14 Jun 04, 2018: ReShape Life sciences Provides Update on FDA Letter to Health Care Providers Related to Intragastric Balloons
  • 6.15 May 31, 2018: Intuitive Surgical Announces Innovative Single Port Platform - the da Vinci SP Surgical System
  • 6.16 May 29, 2018: Intuitive to Begin Direct Operations in India
  • 6.17 May 24, 2018: ReShape Life sciences to Participate at Digestive Disease Week 2018
  • 6.18 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
  • 6.19 May 21, 2018: Globus Medical Names Orthopedic Trauma Division's Vice President of Sales
  • 6.20 May 16, 2018: ReShape Life sciences Trains Eleven Surgeons in Saudi Arabia
  • 6.21 May 16, 2018: DJO Announces Appointment of Mark Dorris as President, Bracing and Supports
  • 6.22 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results
  • 6.23 May 14, 2018: Titan Medical announces Q1 2018 financial results
  • 6.24 May 10, 2018: ReShape Life sciences Announces Submission for Approval of ReShape Balloon in Canada
  • 6.25 May 10, 2018: DJO Global Announces Financial Results for First Quarter 2018
  • 6.26 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
  • 6.27 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
  • 6.28 May 07, 2018: Encision Announces Fourth Quarter Fiscal Year 2018 Results
  • 6.29 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
  • 6.30 May 03, 2018: New Study Shows Robotic-Assisted Surgery Benefits for Inguinal Hernia Repair
  • 6.31 May 03, 2018: Riverview Medical Center Secures Second Surgical Robot, Bringing the Latest Technology in Surgery to the Community
  • 6.32 May 03, 2018: MagForce Publishes Financial Results for the Year 2017 and Operative Highlights
  • 6.33 May 02, 2018: Globus Medical Reports First Quarter 2018 Results
  • 6.34 Apr 26, 2018: Stryker reports first quarter 2018 operating results
  • 6.35 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
  • 6.36 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
  • 6.37 Apr 17, 2018: Intuitive Surgical Reports First Quarter 2018 Financial Results
  • 6.38 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
  • 6.39 Apr 04, 2018: Lankenau Medical Center study shows improved outcomes for patients undergoing minimally invasive aortic valve replacement
  • 6.40 Apr 01, 2018: RUDOLF Medical provides update
  • 6.41 Mar 23, 2018: Heart Institute Inaugurates State-of-The-Art Building Expansion
  • 6.42 Mar 16, 2018: ReShape vBloc to be Featured at the Bariatric Metabolic Surgery Standardization World Consensus Meeting
  • 6.43 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
  • 6.44 Mar 15, 2018: Titan Medical Announces Resignation Of Martin Bernholtz As Director And Chairman
  • 6.45 Mar 13, 2018: Surgical Innovations Group: Final results for the year ended 31 December 2017
  • 6.46 Mar 06, 2018: DJO Global Announces Financial Results For Fourth Quarter And Fiscal Year End 2017
  • 6.47 Mar 06, 2018: Globus Medical Enters Trauma Market
  • 6.48 Mar 05, 2018: Intuitive Surgical, Creator of da Vinci Robotic-Assisted Surgical System, Announces First General Manager in UK & Ireland
  • 6.49 Mar 05, 2018: Shire Launches mypkfit for advate [antihemophilic factor (Recombinant)] in the U.S
  • 6.50 Mar 05, 2018: Intuitive Surgical, Creator of da Vinci Robotic-Assisted Surgical System, Announces First General Manager in UK & Ireland
  • 6.51 Mar 02, 2018: Heritage Valley Health System Adds da Vinci Xi Robotic Surgery System at Beaver and Sewickley Hospitals
  • 6.52 Mar 01, 2018: Sacred Heart Hospital Adds Latest Robotic Surgery Technology
  • 6.53 Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement
  • 6.54 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
  • 6.55 Feb 27, 2018: Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery
  • 6.56 Feb 26, 2018: Test Your Surgical Skills with the da Vinci Robot at Baton Rouge General
  • 6.57 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
  • 6.58 Feb 21, 2018: Globus Medical Announces Full Year and Fourth Quarter 2017 Financial Results
  • 6.59 Feb 13, 2018: Titan Medical Reports 2017 Financial Results
  • 6.60 Feb 08, 2018: Warner Selected As EVP To Lead UT Southwestern Health System
  • 6.61 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
  • 6.62 Feb 05, 2018: Encision Reports Third Quarter Fiscal Year 2018 Results
  • 6.63 Jan 31, 2018: Auris Surgical Sales Takes Surgery to the Next Level With Da Vinci Surgical Systems
  • 6.64 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
  • 6.65 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q